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Plasma Soluble Human Elastin Fragments as an Intra-Aneurysmal
Localized Biomarker for Ruptured Intracranial Aneurysm
Daichi Nakagawa, MD, PhD; Mario Zanaty, MD; Joseph Hudson, BA; Nahom Teferi, MD; Daizo Ishii, MD; Lauren Allan, DO;
Pascal Jabbour, MD; Santiago Ortega-Gutierrez, MD, MS; Edgar A. Samaniego, MD; David M. Hasan, MD
Background-—Fragmentation of the tunica media is a hallmark of intracranial aneurysm formation, often leading to aneurysmal
progression and subsequent rupture. The objective of this study is to determine the plasma level of elastin fragments in the lumen
of ruptured versus unruptured human intracranial aneurysms.
Methods and Results-—One hundred consecutive patients with/without ruptured saccular intracranial aneurysms undergoing
endovascular coiling or stent-assisted coiling were recruited. Blood samples were collected from the lumen of intracranial
aneurysm using a microcatheter. The tip of the microcatheter was placed inside the aneurysm’s sac in close proximity to the inner
wall of the dome. Plasma levels of elastin fragments were measured using an ELISA-based method. Mean plasma level of soluble
human elastin fragments was signiﬁcantly greater in ruptured aneurysms when compared with nonruptured aneurysms
(102.015.5 versus 39.39.6 ng/mL; P<0.001). Mean plasma level of soluble human elastin fragments did not have signiﬁcant
correlation with age, sex, size, or aneurysm location.
Conclusions-—The present study revealed that a signiﬁcantly higher concentration of soluble human elastin fragments in the lumen
of ruptured intracranial aneurysms when compared with nonruptured ones. ( J Am Heart Assoc. 2018;7:e010051. DOI: 10.
1161/JAHA.118.010051.)
Key Words: biomarker • elastin fragments • ELISA • intracranial aneurysm • rupture
F ragmentation of the tunicamedia is a hallmarkof aneurysmformation, progression, and rupture.1 Histological analyses
in animals have characterized thewall of intracranial aneurysms,
ultimately revealing a lack of an internal elastic lamina and
fragmentation of the media. Moreover, analyses of aneurysm
wall tissue has shown a larger number of disorganized mural
cells (vascular smooth muscle cells, myoﬁbroblasts, and
ﬁbroblasts), whereas a few of the walls had entirely lost many
of these cells. However, in all intracranial aneurysms, there is
fragmentation of the internal elastic membrane. This process is
medicated by the uptake of beta-aminopropionitrile, which
suppresses cross-linking of collagen and elastin.2
Elastin is composed of soluble elastin subunits and is 1 of
the major structural matrix proteins in the arterial wall.3
During the aneurysm formation process, an initial tear is
formed. Then the dissection tends to expand to the degraded
elastin layers, along with an inﬂammatory inﬁltrate, a major
source of proteolytic enzymes such as elastases and matrix
metalloproteinases, which, in turn, dramatically promotes the
fragmentation process of the elastin network in the media.4,5
In this article, we aimed to investigatewhether variation exists
between plasma level of elastin fragments in the lumen of
rupturedandunrupturedhuman intracranial saccular aneurysms.
Methods
The data that support the ﬁndings of this study are available
from the corresponding author upon reasonable request.
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Study Population
The study protocol was approved by the University of Iowa
Institutional Review Board. Informed consent was obtained for
all subjects either by direct signature or consultation of
patients’ power of attorney. Consecutive patients undergoing
coiling or stent-assisted coiling for saccular intracranial
aneurysms at our institute between July 2014 and December
2015 were recruited. Patients with connective tissue disease,
emphysema, chronic obstructive pulmonary disease, myocar-
dial infarction, congestive heart failure, and patients taking
steroids or receiving immunosuppressant therapy were
excluded from the study.
Blood Sampling
The technique for intraluminal blood sampling has been previ-
ously described.6,7 Brieﬂy, after femoral arterial access was
obtained, a sheath was inserted, and a guiding catheter was
navigated into the target vessel. Subsequently, a microcatheter
was advanced over a micro guide wire and positioned inside the
aneurysm’s sac. One blood sample (2 mL) was collected from
each aneurysm lumen before stent or coil deployment. Blood
sampling took 3 to 5 minutes for each case. Plasma concen-
tration of soluble elastin fragments (sELAFs) was analyzed using
a commercially available ELISA kit (BioSource.com).
Statistical Analysis
Statistical analysis and graphical display of obtained data
were performed using GraphPad software (version 7.03;
GraphPad Software Inc, San Diego, CA). Statistical signiﬁ-
cance of the difference observed between ruptured and
nonrupture groups was tested using the independent t test, as
well as the Mann–Whitney U test as a nonparametric
alternative. Statistical signiﬁcance between 3 or more groups
was tested using 1-way ANOVA, as well as the Kruskal–Wallis
test as nonparametric alternative. Correlation between
plasma levels of elastin fragments and age or size of the
aneurysm was assessed using the Spearman correlation
coefﬁcient (R). All values are reported as meanSD. In all
cases, a P value <0.05 was considered to indicate statistical
signiﬁcance. Sample size was selected to achieve a power of
at least 90%. The result from our sample-size calculation
required us to recruit at least 88 patients.
Results
Demographic Characteristics
As summarized in Table, 100 patients were enrolled in this
study. Fifty-three females were included. Mean patient age
was 60.912.2 years. Forty-nine aneurysms were ruptured.
Plasma Concentration of Elastin Fragments
Mean of plasma concentration of sELAF, across all treated
patients, was 70.033.8 ng/mL (Table). Results of the
independent t test indicated that the mean of plasma
concentration of sELAF was signiﬁcantly higher in ruptured
aneurysms than unruptured aneurysms (102.015.3 versus
39.39.5 ng/mL; P<0.001; Figure 1). There was no associ-
ation between mean plasma concentrations of sELAF in
ruptured aneurysms and age (P=0.06), sex (female,
100.416.2 ng/mL; male, 103.614.8 ng/mL; P=0.48,
independent t test), aneurysm size (P=0.33), and aneurysm
location (anterior cerebral artery, 101.114.6 ng/mL; middle
cerebral artery, 98.914.9 ng/mL; intracranial artery,
106.619.4 ng/mL; posterior circulation, 102.715.1 ng/mL;
P=0.74, ANOVA; Figure 2A and 2B). Furthermore, there was
Table. Demographic Data for Soluble Human Elastin
Fragments ELISA Assay Patients
Characteristics Mean (SD) or No. (%) Unless Speciﬁed
Total no. of patients 100
Age, y 60.912.2 (range, 24–85)
Female 53 (53)
Ruptured aneurysms 49 (49)
Aneurysm size 7.75.8 mm (range, 2.0–43.0)
Aneurysm location
ACOM 36 (36)
MCA 21 (21)
ICA 23 (23)
Posterior circulation 20 (20)
Elastin fragments (mean
concentration)
70.033.8 ng/mL
ACOM indicates anterior communicating artery; ICA, internal cerebral artery; MCA,
middle cerebral artery.
Clinical Perspective
What Is New?
• A signiﬁcantly higher concentration of soluble elastin
fragment was observed in the lumen of ruptured intracranial
aneurysms when compared with nonruptured ones.
What Are the Clinical Implications?
• The results of our study suggest a pathophysiological
scenario where a gradual increase in elastin degradation
renders the aneurysm unstable, thus precipitating rupture.
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no signiﬁcant difference in mean plasma concentrations of
sELAF between anterior and posterior circulation aneurysms.
This was consistent for both ruptured (101.815.8 versus
102.715.1 ng; P=0.86, independent t test) and unruptured
aneurysms (39.99.6 versus 37.09.5 ng; P=0.40, indepen-
dent t test).
In regard to the unruptured sample, there was no
association between mean plasma concentration of sELAF
and age (P=0.96), sex (female, 59.512.4 ng/mL; male,
62.811.3 ng/mL; P=0.35, Mann–Whitney U test), aneurysm
size (P=0.78), and location (anterior cerebral artery,
40.68.4 ng/mL; middle cerebral artery, 41.19.1 ng/mL;
intracranial artery, 38.011.9 ng/mL; posterior circulation,
37.09.5 ng/mL; P=0.69, ANOVA; Figure 2C and 2D).
Discussion
In this study, we sought to evaluate the level of sELAF present
within the lumen of human intracranial aneurysms. Our
analysis indicated that a signiﬁcantly higher plasma concen-
tration of sELAF exists in lumen of ruptured aneurysms when
compared with unruptured aneurysms.
A ﬂuid-solid-growth model of saccular aneurysm evolution
was developed by Watton et al in 2011.8 The model showed
that aneurysms develop after localized degradation of elastin
results in a perturbation in the arterial geometry. This creates an
altered hemodynamic environment. The collagen fabric adapts,
and the artery achieves a new homeostatic conﬁguration.
Subsequent degradation of elastin is explicitly linked to low wall
shear stress in a conﬁned region of the arterial domain. This
leads to the development of a saccular aneurysm. If the collagen
fabric was able to adapt, the aneurysm stabilizes in size.
Aneurysms are thus subjects to periods with and without
enlargement. Although themodel failed to pinpoint what causes
the progressive slow growth of aneurysms, the researchers
suggested that it is not directly linked to wall shear stress and
that the causes of progression may be multifactorial.
We postulate that an inciting event would lead to a failure
of elastin, precipitating aneurysm growth or rupture. When
Nabaei and Fatouraee included the degradation of elastin as a
function of vascular wall effective stress in their model,9 thus
taking into account the shear-dependent nature of degrada-
tion and the mural-cell–mediated destructive activities, they
found that the model was more consistent with other
computational and clinical studies. Furthermore, the evolving
microstructural properties of the wall during the evolution
process have been better predicted by this new model.
Further highlighting the role of elastin in aneurysmal
rupture, a large retrospective series in China reported that 2
single-nucleotide polymorphisms in elastin genes were
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Figure 1. Luminal soluble elastin frag-
ment concentration in ruptured and unrup-
tured intracranial aneurysms. Results of the
independent t test indicated that the mean
of plasma concentration of elastin frag-
ments was signiﬁcantly higher in ruptured
aneurysms (102.015.3 ng/mL) vs unrup-
tured aneurysms (39.39.5 ng/mL;
P<0.001). ***P<0.001.
Figure 2. Luminal soluble elastin fragment concentration with
respect to age and aneurysm size. A, Relationship between
soluble elastin fragment (sELAF) concentration and age in
ruptured aneurysms (R2=0.07; P=0.06). B, Relationship between
concentration of sELAF and aneurysm size in ruptured aneurysms
(R2=0.02; P=0.33). C, Relationship between concentration of
sELAF and age in unruptured aneurysms (R2=0.00007; P=0.96).
D, Relation between concentration level of sELAF and aneurysm
size in unruptured aneurysms (R2=0.002; P=0.78). R indicates
correlation coefﬁcient; b, slope of regression line.
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associated with intracranial aneurysm formation and rup-
ture.10 Similarly, a study in the Dutch population concluded
that variants and haplotypes within the elastin gene were
associated with risk of sporadic subarachnoid hemorrhage.11
Finally, Onda et al found a strong association between the
intron20/intron23 variant (maps to chromosome 7q11) and
intracranial aneurysms in Japan.12 However, this haplotype
failed to correlate with subarachnoid hemorrhage in the
central European study that examined 30 familial and 175
sporadic subarachnoid hemorrhage cases. This supports
increased genetic heterogeneity among the populations
examined.13 More important, these studies again highlight
the role of elastin in aneurysm formation, progression, and
rupture.14
The result of our study indicated that plasma levels of
sELAF in unruptured intracranial aneurysms were also
presented. This was expected, given that elastin degradation
is an inciting event in the development and progression of
aneurysms. Shinohara et al showed that sELAF was higher in
serum of patients with acute aortic dissections compared with
healthy patients and patients with acute myocardial infarction
at the same age. Using a threshold for positivity (mean of
healthy matched aged patients, 3 SDs), they discovered
that patients with acute aortic dissection with either an open
or a partially open pseudo-lumen were found be 88.9%
positive for sELAF, whereas those with its early closure were
0% positive.4
Although we cannot determine whether the soluble
elastin fragments are elevated because of the rupture or
whether there has been an elevation in soluble fragments
before the rupture, we tend to favor the pathophysiological
scenario where a gradual increase in elastin degradation
renders the aneurysm unstable, thus precipitating rupture.
To accurately test this hypothesis, future studies should
attempt to follow patients with unruptured aneurysms (that
do not require treatment) to evaluate whether subsequent
growth is associated with elevations in sELAF concentra-
tions. Obtaining blood samples for measurements of sELAF
in unruptured aneurysms using a microcatheter is invasive
and not exempt of potential devastating complications.
Consequently, we hope that future work explores sELAF
consequently in peripheral venous blood samples. Further
investigation may ultimately yield a certain threshold
concentration of sELAF, which, when above, would confer
a higher risk of rupture.
Limitations
We did not compare plasma concentration of sELAF in either
the aneurysm wall tissue or venous blood. Moreover, it is
unclear whether the higher levels of elastin reported in
ruptured aneurysms may correspond to the generalized
inﬂammatory process occurring after rupture. These limita-
tions are subjects of future work.
Conclusions
The present study revealed a signiﬁcantly higher concentra-
tion of sELAF in the lumen of ruptured intracranial aneurysms
when compared with nonruptured aneurysms.
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